About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristant #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Court Report | Main | USPTO and EPO to Develop Joint Patent Classification System »

October 25, 2010

Comments

Thanks for the links to the proceedings about Oracea.

A lot of rosacea sufferers are keen for the availability of generic oracea.

Will keep an eye for more information. Please post anything you see from the Feb 14-18 2011 court proceedings.

Hi Guys,

According to:

Mylan Pharmaceuticals Inc. v. Galderma Laboratories Inc. et al.
1:10-cv-00892; filed October 18, 2010

"Trial in the Oracea Patent Litigation is scheduled for February 14-18, 2011"

Are there any updates on this now that that date has passed?

thanks,
davidp.

The comments to this entry are closed.

August 2019

Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31